Latest Transformation News

Lumos Diagnostics has secured a key FDA 510(k) clearance with CLIA waiver for its FebriDx rapid test, unlocking a US$1 billion-plus market opportunity and triggering milestone payments exceeding US$6 million. The company reported a 37% revenue jump in Q3 FY26, supported by a A$20 million placement and ongoing clinical and development projects.

ASX has successfully deployed Release 1 of its CHESS system, introducing a modern clearing platform designed to handle increased trading volumes and improve resilience. The rollout marks a key step in ASX's technology modernisation strategy, with Release 2 on track for 2029.

Kinetiko Energy is advancing a staged development strategy to unlock its 6 trillion cubic feet gas resource in South Africa, targeting first revenues within 18 months through a capital-efficient, risk-managed approach.

Emyria has unveiled the Empax Global Partnership Program, a high-margin clinical delivery platform targeting international drug sponsors amid growing demand for psychedelic-assisted mental health treatments.

Green360 Technologies has produced its first commercial batch of Eco-Clay under a tolling deal with Calix, advancing its low-carbon cement alternative towards market entry in Victoria by mid-2026.

Matrix Composites & Engineering has agreed to a full acquisition by Advanced Innergy Holdings at $0.40 per share, delivering shareholders a premium of up to 68% over recent trading prices. The deal, backed unanimously by Matrix’s board, awaits shareholder and court approval with completion targeted for July 2026.

Trade Window Holdings has announced the unexpected resignation of founding CEO AJ Smith due to illness, with COO Dewald van Rensburg stepping in as acting CEO. The board is currently evaluating options for a permanent replacement.

Electro Optic Systems (ASX: EOS) wraps up a three-year turnaround, reporting a $459 million order backlog despite a 27% revenue drop. The company expands its counter-drone and space control portfolio with the acquisition of the UK-based Interceptor business and a pending deal for MARSS, a European command-and-control software provider.

Life360 has reported its first full year of profitability alongside a 32% revenue surge to $489.5 million in 2025, driven by user growth, new Pet GPS subscriptions, and a strategic advertising platform acquisition.

Eden Innovations has unveiled EdenShield®, a new division focused on commercialising advanced carbon nanotube-enhanced materials and dual-fuel systems for defence and critical infrastructure, aiming to tap into a rapidly expanding global aerospace and defence market.

Orthocell has swiftly converted regulatory approval into clinical use with the first Remplir™ surgery completed in a US Department of Defense hospital, marking a key step in its US commercial expansion.

Resolution Minerals has appointed seasoned mining executive Brett Lynch as a non-executive director to bolster its U.S. growth strategy ahead of a NASDAQ listing. Lynch’s proven North American critical minerals expertise aligns with the company’s ambitions at its Horse Heaven project in Idaho.